2018 / 06

Next Paper
DOI: 10.24075/brsmu.2018.079

ORIGINAL RESEARCH

A novel spheroid model for preclinical intercellular nanophotosensitizer-mediated tumor study

Maklygina YuS1, Romanishkin ID1, Ryabova AV1, Yakavec IV2,3, Bolotin L2, Loschenov VB1,4
About authors

1 Prokhorov General Physics Institute of the Russian Academy of Sciences, Moscow

2 Research Centre for Automatic Control of Nancy, University of Lotaringia, Nancy, France

3 The Belarusian State University, Minsk, Belarus

4 National Research Nuclear University MEPhI, Moscow

Correspondence should be addressed: Yuliya S. Maklygina
Vavilova 38, Moscow, 119991; ur.usm.scisyhp@avonosmas.su

About paper

Funding: this work was supported by the Ministry of Education and Science of the Russian Federation (Agreement RFMEFI61618X0096 # 14.616.21.0096 of February 12, 2018).

Received: 2018-06-26 Accepted: 2018-10-23 Published online: 2018-12-30
|
  1. Breymayer J, Rück A, Ryabova AV, Loschenov VB, Steiner RW. Fluorescence Investigation of the Effect of Monocytes/Macrophages and Skin Cells on Aluminium Phthalocyanine Nanoparticles. Journal Photodiagnosis and Photodynamic Therapy. 2014; 11(3): 380–90.
  2. Vasilchenko SYu, Volkova AI, Ryabova AV, Loschenov VB, Konov VI, Mamedov AA et al. Application of aluminum phthalocyanine nanoparticles for fluorescent diagnostics in dentistry and skin autotransplantology. J Biophoton. 2010; 3 (5–6): 336–46.
  3. Chiarante N, García Vior MC, Awruch J, Marino J, Roguin LP. Phototoxic action of a zinc (II) phthalocyanine encapsulated into poloxamine polymeric micelles in 2D and 3D colon carcinoma cell cultures. J Photochem Photobiol B. 2017; 170: 140–51.
  4. Waite CL, Roth CM. Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities. Crit Rev Biomed Eng. 2012; 40: 21–41.
  5. Kumari P, Jain S, Ghosh B, Zorin V, Biswas S. Polylactide- Based Block Copolymeric Micelles Loaded with Chlorin e6 for Photodynamic Therapy: In Vitro Evaluation in Monolayer and 3D Spheroid Models. Mol Pharm. 2017 Nov 6; 14 (11): 3789–800.
  6. Patel NR, Aryasomayajula B, Abouzeid AH, Torchilin VP. Cancer cell spheroids for screening of chemotherapeutics and drug- delivery systems. Ther Deliv. 2015; (6): 509–20.
  7. Khanna S, Bhatt AN, Dwarakanath BS. Chapter 11 — multicellular spheroid: 3-D tissue culture model for cancer research A2. In: Ashish S Verma, Singh A, editors. Animal Biotechnology. San Diego: Academic Press, 2014: 195–210.
  8. Kimlin LC, Casagrande G, Virador VMю In vitro three-dimensional (3D) models in cancer research: an update. Mol Carcinog. 2013; (52): 167–82.
  9. Baker BM, Chen CS. Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues. J Cell Sci. 2012; (125): 3015–24.
  10. Wartenberg M et al. Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor (HIF-1) and reactive oxygen species. FASEB J. 2003; (17): 503–5.
  11. Evans CL. Three-dimensional in vitro cancer spheroid models for photodynamic therapy: strengths and opportunities. Front Phys. 2015; 3 (15): 1–7.
  12. Yakavets I, Yankovsky I, Millard M, Lamy L, Lassalle HP, Wiehe A et al. The alteration of temoporfin distribution in multicellular tumor spheroids by β-cyclodextrins. Int J Pharm. 2017; 529 (1–2): 568–75.
  13. Ricketts KP, Cheema U, Nyga A, Castoldi A, Guazzoni C, Magdeldin T et al. A 3D in vitro cancer model as a platform for nanoparticle uptake and imaging investigations. 2014; 10 (19): 3954–61.
  14. Kapinus VN, Kaplan MA, Yaroslavtseva-Isayeva EV, Spichenkova IS. Photodynamic therapy for head and neck basal cell skin cancer with additional interstitial laser irradiation. Biomedical Photonics. 2017; 6 (4): 20–6.
  15. Abraham JA, Golubnitschaja O. Time for paradigm change in management of hepatocellular carcinoma: is a personalized approach on the horizon? Per Med. 2016; 13 (5): 455–67.
  16. Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W, Kunz-Schughart LA. Multicellular tumor spheroids: an underestimated tool is catching up again. J Biotechnol. 2010; (148): 3–15.
  17. Josef LB, Boyle RW. Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics. Theranostics. 2012; (2): 916–66.
  18. Franken NAP, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc. 2006; (1): 2315–9.
  19. Dreher MR, Liu W, Michelich CR, Dewhirst MW, Yuan F, Chilkoti A. Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. J Natl Cancer Inst. 2006; (98): 335–44.
  20. Dobiasova M, Urbanova Z, Samanek M Relations between particle size of HDL and LDL lipoproteins and cholesterol esterification rate. Physiol Res Acad Sci Bohemoslov. 2005; (54): 159–65.
  21. Kitamura T, Qian BZ, Pollard JW. Immune cell promotion of metastasis. Nat Rev Immunol. 2015; 15 (2): 73–86.
  22. Kumar V, Patel S, Tcyganov E, Gabrilovich DI. The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. Trends Immunol. 2016; 37 (3): 208–20.
  23. Long L, Yin M, Min W. 3D Co-culture System of Tumor-associated Macrophages and Ovarian Cancer. Cells Bio Protoc. 2018; 8 (8).
  24. Sherman H, Gitschier HJ, Rossi AE. A novel three-dimensional immune oncology model for high-throughput testing of tumoricidal activity. Front Immunol. 2018 Apr 23; (9): 857.